Both in Pharmaceuticals
Celularity vs China Pharma Holdings
Over the past year CELU returned −53.0% and CPHI returned −64.8%; their daily moves had a correlation of 0.07.
CELU −53.0% CPHI −64.8%Growth of $1, one year, split-adjusted
| Metric | CELU | CPHI |
|---|---|---|
| Price | $0.9401 | $0.6200 |
| Market cap | $30.5M | $26.7M |
| Today | +18.97% | −1.59% |
| 1 month | −31.4% | −4.6% |
| 6 months | −2.1% | +12.7% |
| Year to date | −15.3% | −48.8% |
| 1 year | −55.0% | — |
| Revenue growth (YoY) | −5.3% | −7.5% |
| Gross margin | 56.8% | 8.8% |
| Net margin | 10.1% | −153.8% |
| P/E (TTM) | — | — |
| Price / sales | 1.6× | 6.8× |
| Net cash | -$37.1M | -$3.3M |
| Dividend yield | — | — |
| Volatility (60d) | 222.5% | 91.3% |
| Short % of float | 6.7% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).